Durand Benjamin, Stoetzel Corinne, Schaefer Elise, Calmels Nadège, Scheidecker Sophie, Kempf Nadine, De Melo Charlie, Guilbert Anne-Sophie, Timbolschi Dana, Donato Leonardo, Astruc Dominique, Sauer Arnaud, Antal Maria Cristina, Dollfus Hélène, El Chehadeh Salima
Service de génétique médicale, Institut de Génétique Médicale d'Alsace (IGMA), Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
Laboratoire de Génétique Médicale, INSERM U1112, Institut de Génétique Médicale d'Alsace (IGMA), Université de Strasbourg, Strasbourg, France.
Eur J Med Genet. 2020 Apr;63(4):103857. doi: 10.1016/j.ejmg.2020.103857. Epub 2020 Jan 21.
Frank-ter Haar syndrome (FTHS) is a rare autosomal recessive syndrome resulting from mutations in the SH3PXD2B gene involved in the formation of podosomes and invadopodia which have a role in extracellular matrix remodelling and cell migration. FTHS is characterized by facial dysmorphism, megalocornea, inconstant glaucoma, variable developmental delay, skeletal and cardiac anomalies. To date, 40 patients have been reported in the literature with a clinical diagnosis of FTHS, only 20 patients having identified mutations. We present a review of these 20 reported patients and describe a patient born to non-consanguineous parents, with intrauterine growth retardation, hypotonia, congenital glaucoma, caudal appendix, scoliosis, camptodactyly, ventricular septal defect, thin corpus callosum and craniofacial features suggestive of FTHS. Clinical evolution resulted in buphthalmos worsening, coarsening of the facial features and respiratory failure leading to death at 4,5 months. Diagnosis was confirmed by the identification of a previously known homozygous mutation c.969delG, p.(Arg324Glyfs*19) in SH3PXD2B. This is the first description of very severe phenotype with lethal respiratory impairment in FTHS. Since very few patients are described in the literature, and 2 out of the 3 patients carrying the c.969delG mutation had a favourable clinical course, more cases are needed to better characterize the phenotype and understand the natural history of this syndrome. Furthermore, we hypothesize that the alteration of podosomes function could lead to a reduction of the extracellular matrix degradation and accumulation of the latter in the extracellular space, which might explain the coarsening of the facial features and the severe refractory glaucoma.
弗兰克 - 特哈尔综合征(FTHS)是一种罕见的常染色体隐性综合征,由SH3PXD2B基因突变引起,该基因参与了足小体和侵袭性伪足的形成,而足小体和侵袭性伪足在细胞外基质重塑和细胞迁移中发挥作用。FTHS的特征包括面部畸形、巨角膜、不稳定性青光眼、可变的发育迟缓、骨骼和心脏异常。迄今为止,文献报道了40例临床诊断为FTHS的患者,其中仅20例患者的突变已被确定。我们对这20例已报道的患者进行了综述,并描述了一名非近亲结婚父母所生的患者,该患者有宫内生长迟缓、肌张力减退、先天性青光眼、尾状阑尾、脊柱侧弯、屈曲指、室间隔缺损、胼胝体变薄以及提示FTHS的颅面特征。临床病程导致眼球增大恶化、面部特征变粗以及呼吸衰竭,患者在4.5个月时死亡。通过鉴定SH3PXD2B基因中先前已知的纯合突变c.969delG,p.(Arg324Glyfs*19),确诊了该疾病。这是首次对FTHS中具有致命性呼吸障碍的非常严重表型进行描述。由于文献中描述的患者极少,并且携带c.969delG突变的3例患者中有2例临床病程良好,因此需要更多病例来更好地描述该综合征的表型并了解其自然史。此外,我们推测足小体功能的改变可能导致细胞外基质降解减少并在细胞外空间积聚,这可能解释了面部特征变粗和严重难治性青光眼的原因。